Greencore Group /£GNC

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Greencore Group

Greencore Group, listed on the London Stock Exchange under the ticker symbol GNC, operates in the food industry, primarily focusing on the manufacture of convenience foods. It was founded in 1991 and is headquartered in Ireland. The company serves both the UK and Irish markets, providing a wide range of ready-to-eat products for major supermarket chains.

Ticker

£GNC

Primary listing

LSE

Employees

13,300

Headquarters

Dublin, Ireland

Greencore Group Metrics

BasicAdvanced
£1B
19.40
£0.12
1.11
£0.02
0.86%

What the Analysts think about Greencore Group

Analyst ratings (Buy, Hold, Sell) for Greencore Group stock.

Bulls say / Bears say

Significant scale and cost synergies: the £1.2 billion acquisition of Bakkavor will create a combined convenience-food group with approximately £4 billion in annual revenue and is expected to deliver meaningful synergies in manufacturing, distribution, purchasing, administration, and supply-chain operations, strengthening Greencore’s competitive positioning (FT).
Enhanced market share in key retailers: following the deal, Greencore shareholders will own about 56% of the combined entity, solidifying the company’s status as a leading supplier to major UK supermarkets such as Tesco, M&S, and Waitrose, and leveraging Bakkavor’s established customer base for cross-selling opportunities (Reuters).
Robust end-market demand sustains growth: despite industry cost pressures, Greencore’s growth has been underpinned by strong demand for pre-packaged convenience foods, validating the business model and positioning the company to capture ongoing consumer preference for ready-to-eat products (Reuters).
High acquisition premium and immediate market skepticism: Greencore’s offer for Bakkavor at 200 pence per share represented a 32.5% premium, prompting a 3% drop in Greencore’s share price on the deal announcement, indicating perceived overvaluation and dilution risk for existing shareholders (Reuters).
Integration and financing risks loom large: the £1.2 billion cash-and-stock deal spans multiple geographies (UK, China, US) and includes contingent value rights tied to the sale of Bakkavor’s US business by mid-2026, exposing Greencore to execution complexity and potential refinancing pressures amid cost headwinds (Reuters).
Deal approval remains uncertain: the acquisition is subject to both shareholder and regulatory approval, creating timing uncertainty that could delay synergy realization and leave Greencore exposed to antitrust scrutiny and potential transaction adjustments (FT).
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.

Greencore Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Greencore Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £GNC

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs